Authors
Latest:
CMSC Live: 2024 Annual Meeting Day 3Host Jeffrey Wilken, PhD, chats with Marijean Buhse, PhD, RN, NP-C, MSCN; Amy Sullivan, PsyD, ABPP; and John DeLuca, PhD, ABPP, FACRM, FAPA, FAPS, FNAN, about the third day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
New Treatment Guidelines for Restless Legs Syndrome and Shifting Away From Dopamine Agonists: John Winkelman, MD, PhDThe chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital talked about the new clinical guidelines for treating restless legs syndrome which emphasize the risks of dopamine agonists and advocate for alternative therapies. [WATCH TIME: 8 minutes]
Latest:
Addressing Unmet Needs in Narcolepsy Management: Practical Insight for Community-Based PhysiciansClosing out his discussion on narcolepsy management, Chris Winter, MD, highlights current unmet needs and shares practical advice for community physicians.
Latest:
Advancing Equity and Inclusion: Health Literacy for the MS Community and BeyondElizabeth Miller, MA, the manager of health literacy at the National MS Society, discussed the impact of health literacy in the multiple sclerosis community.
Latest:
Equity in the Media and AcademiaThere should be a holistic approach to how the systems in place affect equity: how medicine is practiced and research is conducted, the structure of academic institutions, and how media influence our perceptions of neurologic conditions.
Latest:
Using Digital Data to Improve Parkinson Disease Management: Ro'ee Gilron, PhD & Aiden Arnold, PhD, MScThe lead neuroscientist and lead data scientist at Rune Labs talked about leveraging mobility data to monitor progression in patients with Parkinson disease. [WATCH TIME: 7 minutes]
Latest:
James Grotta, MD: The Future of Stroke Care Going into 2021The vascular neurologist at Memorial Hermann Medical Group explained how clinical stroke care will change in 2021 amid the COVID-19 pandemic.
Latest:
Outlining Phase 3 VITALIZE and MOBILIZE Trials of Riliprubart in CIDP: Luis Querol, MD, PhDThe neurologist at the Hospital de la Santa Creu, in Barcelona, Spain, outlined the goals and significance of the VITALIZE and MOBILIZE phase 3 trials evaluating riliprubart in standard-of-care and treatment-refractory CIDP populations. [WATCH TIME: 3 minutes]
Latest:
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhDThe expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]
Latest:
AUPN Leadership Minute Episode 14: Challenges of Virtual Residency InterviewsEpisode 14 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Nina Browner, MD, of University of North Carolina School of Medicine. [WATCH TIME: 5 minutes]
Latest:
The Ever-Expanding Multiple Sclerosis TherapeuticsJoin Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
Latest:
Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering PatientsMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Taylor Hess, MD. [LISTEN TIME: 10 minutes]
Latest:
Building a Vibrant Community of Neurology Educators: Tracey Milligan, MD, MS, FAAN, FANA, FAESThe professor and chair of neurology at New York Medical College discussed her extensive involvement in neurology education and the recent efforts to enhance neurology education through various programs. [WATCH TIME: 5 minutes]
Latest:
Emerging Therapies and Unmet Needs in MSDrs Ahmed Zayed and Mark S. Freedman review emerging therapies in the pipeline and unmet needs in the multiple sclerosis treatment landscape, as well as take-home thoughts.
Latest:
Advice for Clinicians Treating SpasticityExperts on spasticity provide advice for practicing clinicians to optimize patient outcomes.
Latest:
Understanding Distinct Differences in Sleep Disorders to Ensure Accurate Diagnosis: Alcibiades J. Rodriguez, MDThe director of the Comprehensive Epilepsy Center—Sleep Center at NYU Langone provided perspective on the overlap in characteristics of sleep disorders and the necessary approach to ensuring accurate diagnosis and initial treatment. [WATCH TIME: 5 minutes]
Latest:
Positive Impact of Ataluren on Walking Ability in Duchenne Muscular Dystrophy: Jeffrey M. Statland, MDAt the 2023 AAN Annual Meeting, the neuromuscular disease specialist and professor of neurology at the University of Kansas Medical Center talked about the phase 3 study investigating ataluren for Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]
Latest:
Integrating Machine Learning, Digital Platforms to Alzheimer Trials: David Bates, PhDThe chief executive officer and co-founder of Linus Health discussed screening tools for early cognitive decline and overcoming the complexities with using new-age technology. [WATCH TIME: 3 minutes]
Latest:
CMSC Live: 2024 Annual Meeting Day 2Host Jeffrey Wilken, PhD, chats with Fred Lublin, MD; Brian Hutchinson, PT, MSCS; and Robert Motl, PhD, about the second day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
Leveraging PET Biomarkers for Alzheimer Diagnosis in Real-World Scenarios: Phillip Kuo, MD, PhD, FACRThe professor in the department of diagnostic radiology at City of Hope talked about using amyloid and tau PET imaging for diagnostic clarity in Alzheimer disease, particularly in complex and atypical patient presentations. [WATCH TIME: 10 minutes]
Latest:
Future Aspirations of Neonatal Seizure Research: Solomon Moshe, MD; Elissa Yozawitz, MDThe duo from Montefiore Medical Center discussed aspects of their recently published recommendations on neonatal seizure diagnosis that need further examining.
Latest:
Management of Neurogenic BladderPanelist discusses how, for managing neurogenic bladder, neurologists should focus on individualized treatment plans emphasizing bladder emptying schedules, antimuscarinic medications when indicated, and clean intermittent catheterization as needed. Regular monitoring of renal function, urinary tract infection prevention, and coordination with urologists are crucial. Patient education about lifestyle modifications and adherence to treatment regimens is essential for optimal outcomes.
Latest:
Navigating an Expanding Treatment Toolbox for MS“Is more always better?”: The age-old question is more relevant than ever as clinicians and patients alike navigate an increasingly crowded MS treatment landscape.
Latest:
Virtual Reality is a Game-Changer During Blood Draws for Pediatric Patients With Spinal Muscular AtrophyIn honor of Spinal Muscular Atrophy (SMA) Awareness Month, Abraham Homer, MS, the gaming technology supervisor and creative technologist at Children's Hospital Colorado, shared how virtual reality transformed care for patients with SMA.
Latest:
Optimizing the Migraine ConsultationProper diagnosis and effective treatment planning can drastically improve quality of life for individuals with migraine.
Latest:
Future of Treating Alzheimer DiseaseDrs Richard S. Isaacson and Marc E. Agronin look to the future of treating Alzheimer disease with the emphasis on early diagnosis.
Latest:
The Broader Impact of Eptinezumab for Chronic Migraine Management: Fawad Khan, MD, FACNS, FAHSThe director of The McCasland Family Comprehensive Headache Center talked about findings from a study that explored the effect of eptinezumab treatment in a broader chronic migraine population. [WATCH TIME: 6 minutes]
